| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | LEDGF | 3.25e-05 | 2 | 107 | 2 | PF11467 | |
| Domain | LEDGF | 3.25e-05 | 2 | 107 | 2 | IPR021567 | |
| Domain | PHD | 7.05e-05 | 75 | 107 | 5 | PF00628 | |
| Domain | Znf_PHD-finger | 9.04e-05 | 79 | 107 | 5 | IPR019787 | |
| Domain | PHD | 1.59e-04 | 89 | 107 | 5 | SM00249 | |
| Domain | Znf_PHD | 1.77e-04 | 91 | 107 | 5 | IPR001965 | |
| Domain | PWWP | 1.94e-04 | 20 | 107 | 3 | SM00293 | |
| Domain | ZF_PHD_2 | 2.16e-04 | 95 | 107 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 2.27e-04 | 96 | 107 | 5 | PS01359 | |
| Domain | - | USP45 MYCBP2 KAT6A ZMYND8 ASH1L MLLT10 PCGF3 PHF3 SCAF11 PDZRN3 | 2.56e-04 | 449 | 107 | 10 | 3.30.40.10 |
| Domain | PWWP | 2.98e-04 | 23 | 107 | 3 | PF00855 | |
| Domain | PWWP_dom | 2.98e-04 | 23 | 107 | 3 | IPR000313 | |
| Domain | Znf_RING/FYVE/PHD | USP45 MYCBP2 KAT6A ZMYND8 ASH1L MLLT10 PCGF3 PHF3 SCAF11 PDZRN3 | 3.05e-04 | 459 | 107 | 10 | IPR013083 |
| Domain | PWWP | 3.39e-04 | 24 | 107 | 3 | PS50812 | |
| Domain | Zinc_finger_PHD-type_CS | 5.27e-04 | 65 | 107 | 4 | IPR019786 | |
| Domain | Znf_FYVE_PHD | 1.58e-03 | 147 | 107 | 5 | IPR011011 | |
| Domain | Kinesin_motor_CS | 1.66e-03 | 41 | 107 | 3 | IPR019821 | |
| Domain | WH1 | 1.73e-03 | 11 | 107 | 2 | SM00461 | |
| Domain | WH1/EVH1_dom | 1.73e-03 | 11 | 107 | 2 | IPR000697 | |
| Domain | WH1 | 1.73e-03 | 11 | 107 | 2 | PF00568 | |
| Domain | Kinesin-like_fam | 1.91e-03 | 43 | 107 | 3 | IPR027640 | |
| Domain | - | 2.04e-03 | 44 | 107 | 3 | 3.40.850.10 | |
| Domain | Kinesin | 2.04e-03 | 44 | 107 | 3 | PF00225 | |
| Domain | KISc | 2.04e-03 | 44 | 107 | 3 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 2.04e-03 | 44 | 107 | 3 | PS00411 | |
| Domain | Kinesin_motor_dom | 2.04e-03 | 44 | 107 | 3 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 2.04e-03 | 44 | 107 | 3 | PS50067 | |
| Domain | WH1 | 2.43e-03 | 13 | 107 | 2 | PS50229 | |
| Domain | p53-like_TF_DNA-bd | 3.48e-03 | 53 | 107 | 3 | IPR008967 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | THOC1 UIMC1 WBP11 SLF1 CDKN2AIP ZMYND8 CAST RBM28 RFC1 SRFBP1 HNRNPD NCOR1 RIF1 PSIP1 ZSCAN21 PHF3 TPX2 SENP6 SCAF11 ZCCHC7 HDGFL2 MTDH PCM1 KNL1 SON | 8.09e-16 | 954 | 115 | 25 | 36373674 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | THOC1 UIMC1 MYCBP2 ZMYND8 CAST UBA2 UFL1 ITPRID2 RFC1 HNRNPD NCOR1 RIF1 PSIP1 PAPOLA MAGED2 PHF3 TPX2 SENP6 SCAF11 PCM1 SON | 1.12e-13 | 774 | 115 | 21 | 15302935 |
| Pubmed | THOC1 UIMC1 CASP8AP2 WBP11 RNMT CDKN2AIP ZMYND8 UBA2 UFL1 CHD2 RFC1 STAT1 NCOR1 RIF1 PSIP1 PAPOLA PHF3 PPP4R2 TPX2 HDGFL2 SON | 1.84e-11 | 1014 | 115 | 21 | 32416067 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | UIMC1 CDKN2AIP RTN4 ZMYND8 CAST RFC1 STAT1 NEK1 RIF1 PSIP1 PAPOLA TPX2 SENP6 GOLGA5 ACBD3 HDGFL2 MTDH PCM1 KNL1 SON | 3.28e-11 | 934 | 115 | 20 | 33916271 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ZMYND8 RFC1 SRFBP1 NCOR1 RIF1 PSIP1 PAPOLA PHF3 TPX2 SCAF11 HDGFL2 MTDH | 1.95e-10 | 283 | 115 | 12 | 30585729 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | SECISBP2L UIMC1 WBP11 MYCBP2 PPP1R9A APC ITPRID2 RBM28 RIF1 TPX2 KIF14 KNL1 SON | 2.47e-10 | 361 | 115 | 13 | 30344098 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | THOC1 UIMC1 CASP8AP2 TBX3 SLF1 ZMYND8 CHD2 RBM28 RFC1 SRFBP1 HNRNPD NCOR1 RIF1 PSIP1 ZSCAN21 PHF3 TPX2 SCAF11 ZCCHC7 HDGFL2 MTDH SON | 2.48e-10 | 1294 | 115 | 22 | 30804502 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | THOC1 WBP11 MYCBP2 PPP1R9A UFL1 ITPRID2 RBM28 HRNR HNRNPD STAT1 CEP350 RIF1 EFNB1 PSIP1 KIF14 MTDH PCM1 SON | 7.71e-09 | 1024 | 115 | 18 | 24711643 |
| Pubmed | UIMC1 MYCBP2 ZMYND8 ASH1L NCOR1 FBN2 PAPOLA TENM3 SPRED1 SPARCL1 ZCCHC7 ACBD3 KNL1 SON | 1.06e-08 | 591 | 115 | 14 | 15231748 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | UIMC1 ZNF280D KAT6A CHD2 RFC1 RIF1 PSIP1 ZSCAN21 PHF3 TPX2 SENP6 SCAF11 MORC3 HDGFL2 | 1.51e-08 | 608 | 115 | 14 | 36089195 |
| Pubmed | USP45 RNMT BMP2K CEP162 CAMLG ASH1L CAST APC CHD2 RBM28 STAT1 ITPR1 PAPOLA ZSCAN21 PPP4R2 GPC4 SPRED1 MTDH | 1.84e-08 | 1084 | 115 | 18 | 11544199 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | THOC1 MYCBP2 KAT6A RBM28 RFC1 HNRNPD RIF1 PSIP1 UPF2 MAGED2 PHF3 TPX2 SCAF11 MTDH SON | 3.36e-08 | 759 | 115 | 15 | 35915203 |
| Pubmed | UIMC1 WBP11 SLF1 HSPA4L ZMYND8 RBM28 MLLT10 HRNR RFC1 PCGF3 STAT1 ZNF284 NCOR1 RIF1 FBN2 MAGED2 ZSCAN21 TPX2 SCAF11 PCM1 | 4.63e-08 | 1429 | 115 | 20 | 35140242 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | UIMC1 BMP2K CAMLG RTN4 ZNF407 CHD2 HNRNPD STAT1 RIF1 FBN2 EFNB1 PSIP1 PHF3 ZCCHC7 MORC3 GOLGA5 MTDH RAB27A | 8.84e-08 | 1203 | 115 | 18 | 29180619 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | THOC1 WBP11 RNMT LRCH2 MYCBP2 ZMYND8 APC UFL1 CHD2 HRNR HNRNPD KIDINS220 PSIP1 UPF2 GPC4 MTDH SON | 1.05e-07 | 1082 | 115 | 17 | 38697112 |
| Pubmed | THOC1 SECISBP2L WBP11 CHD2 RBM28 RFC1 SRFBP1 STAT1 CEP350 RIF1 PSIP1 UPF2 MAGED2 PHF3 TPX2 SCAF11 MTDH PCM1 SON | 1.22e-07 | 1371 | 115 | 19 | 36244648 | |
| Pubmed | WBP11 MYCBP2 CAMLG APC RBM28 CEP350 PHF3 TPX2 KIF14 GOLGA5 ACBD3 PDZRN3 PCM1 KNL1 | 1.51e-07 | 733 | 115 | 14 | 34672954 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | LRCH2 BMP2K CEP162 CAST APC PARD3B CEP350 NCOR1 FBN2 ARHGAP29 KIF14 MORC3 GOLGA5 PDZRN3 PCM1 | 1.52e-07 | 853 | 115 | 15 | 28718761 |
| Pubmed | CASP8AP2 ZNF280D MYCBP2 ZMYND8 APC NCOR1 NEK1 KIF14 GOLGA5 PCM1 KNL1 | 1.54e-07 | 418 | 115 | 11 | 34709266 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.69e-07 | 332 | 115 | 10 | 32786267 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.92e-07 | 184 | 115 | 8 | 32908313 | |
| Pubmed | WBP11 BMP2K MYCBP2 CDKN2AIP CAMLG ITPRID2 NEK1 KIDINS220 EFNB1 GPC4 KIF14 GOLGA5 ACBD3 MTDH RAB27A PCM1 | 2.23e-07 | 1007 | 115 | 16 | 34597346 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | UIMC1 TBX3 WBP11 CDKN2AIP RTN4 STAT1 NCOR1 MAGED2 PHF3 SENP6 MTDH | 2.81e-07 | 444 | 115 | 11 | 34795231 |
| Pubmed | BMP2K CEP162 APC HRNR CEP350 NCOR1 RIF1 KIDINS220 EFNB1 TENM3 MAGED2 GOLGA5 MTDH PCM1 | 3.05e-07 | 777 | 115 | 14 | 35844135 | |
| Pubmed | WBP11 MYCBP2 CEP162 CDKN2AIP PPP1R9A PSD3 ITPRID2 SRFBP1 ITPR1 CEP350 NCOR1 RIF1 PPP4R2 KIF14 GOLGA5 KNL1 | 3.84e-07 | 1049 | 115 | 16 | 27880917 | |
| Pubmed | CASP8AP2 WBP11 MYCBP2 HSPA4L CAMLG RTN4 PSD3 UFL1 ITPRID2 RBM28 ITPR1 KIDINS220 EFNB1 PSIP1 GOLGA5 ACBD3 HDGFL2 MTDH PCM1 | 4.23e-07 | 1487 | 115 | 19 | 33957083 | |
| Pubmed | UIMC1 BMP2K CDKN2AIP PPP1R9A ZMYND8 APC UFL1 CHD2 ITPRID2 SRFBP1 STAT1 RIF1 KIDINS220 PHF3 TPX2 KIF14 SCAF11 HDGFL2 SON | 4.68e-07 | 1497 | 115 | 19 | 31527615 | |
| Pubmed | 5.07e-07 | 209 | 115 | 8 | 36779422 | ||
| Pubmed | UIMC1 ZMYND8 CAST UBA2 RIF1 PSIP1 PHF3 KIF14 ACBD3 HDGFL2 KNL1 | 5.13e-07 | 472 | 115 | 11 | 38943005 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | UIMC1 CASP8AP2 APC UBA2 ITPRID2 NCOR1 PPP4R2 SENP6 KIF14 MORC3 PCM1 KNL1 | 6.19e-07 | 588 | 115 | 12 | 38580884 |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 6.54e-07 | 148 | 115 | 7 | 32538781 | |
| Pubmed | WBP11 MYCBP2 CDKN2AIP ZMYND8 UBA2 RBM28 RFC1 HNRNPD STAT1 NCOR1 PSIP1 ZSCAN21 PPP4R2 TPX2 PCM1 KNL1 | 7.43e-07 | 1103 | 115 | 16 | 34189442 | |
| Pubmed | WBP11 LRCH2 HNRNPD STAT1 RIF1 PAPOLA PHF3 PPP4R2 TPX2 HDGFL2 SON | 1.01e-06 | 506 | 115 | 11 | 30890647 | |
| Pubmed | PPP1R9A DLGAP4 PSD3 PARD3B UFL1 KIDINS220 TENM3 GOLGA5 ACBD3 RAB27A | 1.46e-06 | 421 | 115 | 10 | 36976175 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 2.17e-06 | 440 | 115 | 10 | 34244565 | |
| Pubmed | CAMLG RTN4 CAST UFL1 STAT1 ITPR1 GOLGA5 ACBD3 MTDH RAB27A PCM1 | 3.08e-06 | 568 | 115 | 11 | 37774976 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | 4.26e-06 | 475 | 115 | 10 | 31040226 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | THOC1 BMP2K MYCBP2 RTN4 CAST APC HNRNPD CEP350 UPF2 PHF3 MTDH SON | 5.28e-06 | 724 | 115 | 12 | 36232890 |
| Pubmed | WBP11 MYCBP2 CAMLG KIF21A ZMYND8 ASH1L APC STAT1 CEP350 SENP6 SPRED1 SPARCL1 MORC3 ACBD3 PCM1 SOS2 | 5.28e-06 | 1285 | 115 | 16 | 35914814 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 6.86e-06 | 394 | 115 | 9 | 27248496 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | BMP2K HSPA4L CDKN2AIP ZMYND8 UBA2 UFL1 CHD2 RBM28 RFC1 HNRNPD STAT1 NCOR1 UPF2 MORC3 MTDH SON | 7.26e-06 | 1318 | 115 | 16 | 30463901 |
| Pubmed | THOC1 UIMC1 TBX3 BMP2K HSPA4L CDKN2AIP ITPRID2 RBM28 SCAF11 MTDH PCM1 | 8.70e-06 | 634 | 115 | 11 | 34591612 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 16337983 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 21457704 | ||
| Pubmed | Kidins220/ARMS interacts with Pdzrn3, a protein containing multiple binding domains. | 1.08e-05 | 2 | 115 | 2 | 22609016 | |
| Pubmed | LEDGF and HDGF2 relieve the nucleosome-induced barrier to transcription in differentiated cells. | 1.08e-05 | 2 | 115 | 2 | 31616795 | |
| Pubmed | KRAP tethers IP3 receptors to actin and licenses them to evoke cytosolic Ca2+ signals. | 1.08e-05 | 2 | 115 | 2 | 34301929 | |
| Pubmed | HRP-2 determines HIV-1 integration site selection in LEDGF/p75 depleted cells. | 1.08e-05 | 2 | 115 | 2 | 23046603 | |
| Pubmed | EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. | 1.08e-05 | 2 | 115 | 2 | 17906625 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 36030740 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 15797927 | ||
| Pubmed | mRNA Cap Methyltransferase, RNMT-RAM, Promotes RNA Pol II-Dependent Transcription. | 1.08e-05 | 2 | 115 | 2 | 29719263 | |
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 38786982 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 23909438 | ||
| Pubmed | 1.08e-05 | 2 | 115 | 2 | 14506248 | ||
| Pubmed | CASP8AP2 RNMT SUSD6 CEP162 KIF21A RTN4 AKNA UFL1 SENP6 SCAF11 | 1.09e-05 | 529 | 115 | 10 | 14621295 | |
| Pubmed | 1.26e-05 | 538 | 115 | 10 | 28524877 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.38e-05 | 430 | 115 | 9 | 35044719 | |
| Pubmed | 1.80e-05 | 339 | 115 | 8 | 37232246 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.87e-05 | 341 | 115 | 8 | 32971831 | |
| Pubmed | LRCH2 KAT6A ASH1L APC UFL1 STAT1 CEP350 NCOR1 NEK1 PHF3 USP4 | 1.88e-05 | 689 | 115 | 11 | 36543142 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | RTN4 CAST ITPRID2 STAT1 KIDINS220 TENM3 ARHGAP29 SPRED1 GOLGA5 ACBD3 | 1.92e-05 | 565 | 115 | 10 | 25468996 |
| Pubmed | 2.07e-05 | 453 | 115 | 9 | 29656893 | ||
| Pubmed | UIMC1 WBP11 HSPA4L KIF21A PPP1R9A ASH1L CHD2 HNRNPD NCOR1 PSIP1 MAGED2 GPC4 SCN9A DNAH8 HDGFL2 MTDH | 2.20e-05 | 1442 | 115 | 16 | 35575683 | |
| Pubmed | ZMYND8 RBM28 RFC1 HNRNPD NCOR1 RIF1 PSIP1 PHF3 TPX2 SCAF11 MTDH SON | 2.51e-05 | 847 | 115 | 12 | 35850772 | |
| Pubmed | 2.72e-05 | 469 | 115 | 9 | 27634302 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | MYCBP2 CEP162 PSD3 APC PARD3B ITPRID2 CEP350 NEK1 PHF3 KIF14 MORC3 PCM1 | 2.94e-05 | 861 | 115 | 12 | 36931259 |
| Pubmed | 3.22e-05 | 268 | 115 | 7 | 33640491 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 17416745 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 33477970 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 15371438 | ||
| Pubmed | ASH1L Links Histone H3 Lysine 36 Dimethylation to MLL Leukemia. | 3.24e-05 | 3 | 115 | 2 | 27154821 | |
| Pubmed | STAT1 expression is not required for polyp formation in Min mice. | 3.24e-05 | 3 | 115 | 2 | 17683066 | |
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 25787750 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 17000771 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 22992961 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 33239430 | ||
| Pubmed | 3.24e-05 | 3 | 115 | 2 | 38642666 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | BMP2K MYCBP2 HSPA4L CAMLG RTN4 UFL1 ITPRID2 RBM28 HNRNPD ITPR1 UPF2 MAGED2 GOLGA5 ACBD3 MTDH SON | 3.42e-05 | 1496 | 115 | 16 | 32877691 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | WBP11 ZMYND8 RBM28 HRNR RFC1 HNRNPD PSIP1 SCAF11 HDGFL2 MTDH | 3.42e-05 | 605 | 115 | 10 | 28977666 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | 4.33e-05 | 498 | 115 | 9 | 36634849 | |
| Pubmed | 4.75e-05 | 504 | 115 | 9 | 34432599 | ||
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 5.19e-05 | 289 | 115 | 7 | 23752268 | |
| Pubmed | 5.30e-05 | 121 | 115 | 5 | 22412018 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 5.73e-05 | 123 | 115 | 5 | 26912792 | |
| Pubmed | Antigens recognized by autologous antibody in patients with renal-cell carcinoma. | 5.81e-05 | 63 | 115 | 4 | 10508479 | |
| Pubmed | 5.81e-05 | 63 | 115 | 4 | 34718347 | ||
| Pubmed | 6.47e-05 | 653 | 115 | 10 | 22586326 | ||
| Pubmed | IDO1+ Paneth cells promote immune escape of colorectal cancer. | 6.48e-05 | 4 | 115 | 2 | 32444775 | |
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 33932349 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 16270321 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 18952841 | ||
| Pubmed | 6.48e-05 | 4 | 115 | 2 | 31484922 | ||
| Pubmed | 6.53e-05 | 407 | 115 | 8 | 12693553 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 6.97e-05 | 208 | 115 | 6 | 33230847 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | THOC1 ITPRID2 RBM28 HRNR RFC1 HNRNPD PSIP1 UPF2 MAGED2 PHF3 TPX2 KIF14 SCAF11 MTDH | 7.18e-05 | 1257 | 115 | 14 | 36526897 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | THOC1 KIF27 ZNF280D HSPA4L RTN4 UFL1 RFC1 HNRNPD STAT1 RIF1 KIDINS220 PSIP1 MAGED2 KIF14 MTDH | 7.34e-05 | 1425 | 115 | 15 | 30948266 |
| Pubmed | 7.35e-05 | 210 | 115 | 6 | 16565220 | ||
| Pubmed | THOC1 BMP2K HSPA4L RTN4 UFL1 ITPRID2 RBM28 RFC1 HNRNPD ITPR1 PSIP1 KIF14 MTDH RAB27A PCM1 | 8.25e-05 | 1440 | 115 | 15 | 30833792 | |
| Pubmed | WBP11 LRCH2 MYCBP2 KIF21A PPP1R9A DLGAP4 APC NCOR1 MAGED2 GPR158 HOMER2 PCM1 | 8.58e-05 | 963 | 115 | 12 | 28671696 | |
| Interaction | SMC5 interactions | THOC1 UIMC1 WBP11 SLF1 CDKN2AIP ZMYND8 CAST UBA2 RBM28 RFC1 SRFBP1 HNRNPD NCOR1 RIF1 PSIP1 ZSCAN21 PHF3 TPX2 SENP6 SCAF11 ZCCHC7 HDGFL2 MTDH PCM1 KNL1 SON | 3.71e-11 | 1000 | 113 | 26 | int:SMC5 |
| Interaction | CBX3 interactions | UIMC1 ZNF280D ZMYND8 UBA2 UFL1 RFC1 PCGF3 SRFBP1 NCOR1 RIF1 PSIP1 ZSCAN21 PHF3 TPX2 SENP6 KIF14 HDGFL2 KNL1 | 1.99e-08 | 646 | 113 | 18 | int:CBX3 |
| Interaction | SSRP1 interactions | THOC1 KAT6A ZMYND8 UFL1 CHD2 MLLT10 RFC1 SRFBP1 HNRNPD NCOR1 RIF1 PHF3 KIF14 SCAF11 MORC3 HDGFL2 MTDH SON | 4.85e-08 | 685 | 113 | 18 | int:SSRP1 |
| Interaction | NUP43 interactions | CASP8AP2 ZNF280D CDKN2AIP ZMYND8 ASH1L APC CCDC168 ITPRID2 RBM28 RFC1 NCOR1 RIF1 PSIP1 SENP6 ZCCHC7 KNL1 SON | 7.27e-08 | 625 | 113 | 17 | int:NUP43 |
| Interaction | H3C1 interactions | UIMC1 WBP11 ZNF280D KAT6A ZMYND8 ASH1L CAST RBM28 RFC1 SRFBP1 NCOR1 RIF1 PSIP1 ZSCAN21 PHF3 TPX2 SENP6 MORC3 DNAH8 HDGFL2 | 1.27e-07 | 901 | 113 | 20 | int:H3C1 |
| Interaction | NAA40 interactions | UIMC1 CDKN2AIP RTN4 ZMYND8 CAST RFC1 STAT1 NEK1 RIF1 PSIP1 PAPOLA TPX2 SENP6 GOLGA5 ACBD3 HDGFL2 MTDH PCM1 KNL1 SON | 4.70e-07 | 978 | 113 | 20 | int:NAA40 |
| Interaction | SNRNP40 interactions | CASP8AP2 WBP11 ZNF280D CDKN2AIP KAT6A RBM28 RFC1 HNRNPD NCOR1 SENP6 SCAF11 ZCCHC7 HDGFL2 MTDH KNL1 SON | 5.31e-07 | 637 | 113 | 16 | int:SNRNP40 |
| Interaction | H2BC8 interactions | UIMC1 ZNF280D ZMYND8 RFC1 SRFBP1 RIF1 PSIP1 PAPOLA ZSCAN21 PHF3 TPX2 SENP6 SCAF11 MORC3 HDGFL2 | 7.92e-07 | 576 | 113 | 15 | int:H2BC8 |
| Interaction | PSIP1 interactions | 2.34e-06 | 205 | 113 | 9 | int:PSIP1 | |
| Interaction | TERF2IP interactions | THOC1 UIMC1 WBP11 ZMYND8 UBA2 RFC1 NCOR1 RIF1 PSIP1 PHF3 TPX2 SENP6 SCAF11 KNL1 | 2.59e-06 | 552 | 113 | 14 | int:TERF2IP |
| Interaction | PPP1CC interactions | SECISBP2L UIMC1 WBP11 BMP2K MYCBP2 PPP1R9A APC UFL1 ITPRID2 RBM28 NCOR1 RIF1 TPX2 KIF14 KNL1 SON | 3.60e-06 | 738 | 113 | 16 | int:PPP1CC |
| Interaction | H3-3A interactions | UIMC1 ZNF280D KAT6A ASH1L UFL1 CHD2 RFC1 RIF1 PSIP1 ZSCAN21 PHF3 TPX2 SENP6 SCAF11 MORC3 HDGFL2 | 4.34e-06 | 749 | 113 | 16 | int:H3-3A |
| Interaction | H2BC9 interactions | SECISBP2L CASP8AP2 USP45 LRCH2 ABCA13 DLGAP4 ASH1L HNRNPD CEP350 PSIP1 GPC4 HDGFL2 | 7.82e-06 | 446 | 113 | 12 | int:H2BC9 |
| Interaction | CEP104 interactions | 1.08e-05 | 89 | 113 | 6 | int:CEP104 | |
| Interaction | PARP1 interactions | UIMC1 MYCBP2 CDKN2AIP SPPL3 UBA2 UFL1 ITPRID2 RBM28 HRNR RFC1 SRFBP1 HNRNPD KIDINS220 PSIP1 ZSCAN21 PHF3 TPX2 SENP6 SCAF11 MORC3 HDGFL2 | 1.19e-05 | 1316 | 113 | 21 | int:PARP1 |
| Interaction | XRCC6 interactions | TBX3 CDKN2AIP ZMYND8 UFL1 RFC1 SRFBP1 HNRNPD NCOR1 RIF1 PSIP1 PAPOLA PHF3 TPX2 KIF14 SCAF11 HDGFL2 MTDH | 1.60e-05 | 928 | 113 | 17 | int:XRCC6 |
| Interaction | ZNF408 interactions | 1.76e-05 | 145 | 113 | 7 | int:ZNF408 | |
| Interaction | BRCA1 interactions | THOC1 UIMC1 RNMT SLF1 ZNF280D HSPA4L CDKN2AIP ITPRID2 RBM28 RFC1 HNRNPD STAT1 ITPR1 CEP350 RIF1 ZSCAN21 TPX2 MORC3 GOLGA5 KNL1 | 1.89e-05 | 1249 | 113 | 20 | int:BRCA1 |
| Interaction | SUMO2 interactions | UIMC1 CASP8AP2 ZMYND8 CAST UBA2 NCOR1 RIF1 PHF3 TPX2 SENP6 SCAF11 ZCCHC7 MORC3 | 2.73e-05 | 591 | 113 | 13 | int:SUMO2 |
| Interaction | CLMP interactions | 2.74e-05 | 11 | 113 | 3 | int:CLMP | |
| Interaction | STX4 interactions | CAMLG RTN4 SPPL3 APC UFL1 ITPRID2 KIDINS220 EFNB1 GOLGA5 ACBD3 MTDH | 2.91e-05 | 428 | 113 | 11 | int:STX4 |
| Interaction | HECTD1 interactions | THOC1 MYCBP2 HSPA4L KAT6A APC RBM28 RFC1 HNRNPD RIF1 PSIP1 UPF2 MAGED2 PHF3 TPX2 SCAF11 MTDH SON | 3.37e-05 | 984 | 113 | 17 | int:HECTD1 |
| Interaction | TMT1A interactions | CAMLG RTN4 UFL1 CCDC168 ITPR1 KIDINS220 GOLGA5 ACBD3 MTDH RAB27A | 3.47e-05 | 359 | 113 | 10 | int:TMT1A |
| Interaction | YWHAZ interactions | MYCBP2 CEP162 KAT6A PSD3 APC PARD3B UFL1 ITPRID2 HRNR HNRNPD ITPR1 NCOR1 NEK1 PHF3 ARHGAP29 KIF14 SCAF11 ZCCHC7 MORC3 PCM1 | 4.10e-05 | 1319 | 113 | 20 | int:YWHAZ |
| Interaction | FMR1 interactions | THOC1 LRCH2 MYCBP2 KAT6A ZMYND8 APC UFL1 HNRNPD NCOR1 KIF14 MTDH PCM1 | 4.78e-05 | 536 | 113 | 12 | int:FMR1 |
| Interaction | PML interactions | UIMC1 CASP8AP2 TBX3 WBP11 RTN4 KAT6A STAT1 NCOR1 MAGED2 ZSCAN21 PHF3 SENP6 KIF14 MORC3 MTDH KNL1 | 6.41e-05 | 933 | 113 | 16 | int:PML |
| Interaction | FLNA interactions | USP45 BMP2K CEP162 KAT6A SPPL3 APC UFL1 CHD2 ITPRID2 HNRNPD KIF14 USP4 MTDH | 7.00e-05 | 648 | 113 | 13 | int:FLNA |
| Interaction | MYCN interactions | THOC1 WBP11 RNMT HSPA4L CDKN2AIP ZMYND8 CHD2 CHGB RBM28 HRNR SRFBP1 HNRNPD NEK1 PSIP1 UPF2 PHF3 SCAF11 HDGFL2 MTDH SON | 7.18e-05 | 1373 | 113 | 20 | int:MYCN |
| Interaction | DDX23 interactions | WBP11 UFL1 CHD2 RBM28 SRFBP1 PHF3 KIF14 SCAF11 ACBD3 HDGFL2 PCM1 | 8.16e-05 | 480 | 113 | 11 | int:DDX23 |
| Interaction | MECP2 interactions | THOC1 WBP11 RNMT LRCH2 MYCBP2 ZMYND8 APC UFL1 CHD2 RBM28 HRNR HNRNPD NCOR1 KIDINS220 PSIP1 UPF2 GPC4 MTDH SON | 9.36e-05 | 1287 | 113 | 19 | int:MECP2 |
| Interaction | BACE2 interactions | 9.81e-05 | 82 | 113 | 5 | int:BACE2 | |
| Interaction | RAC2 interactions | PDE8A PPP1R9A PSD3 UFL1 CHGB ITPR1 KIDINS220 EFNB1 TENM3 KIF14 GOLGA5 ACBD3 MTDH | 1.04e-04 | 674 | 113 | 13 | int:RAC2 |
| Interaction | PABPN1 interactions | 1.05e-04 | 192 | 113 | 7 | int:PABPN1 | |
| Interaction | TRIM21 interactions | CASP8AP2 IGFN1 MYCBP2 AKNA APC UFL1 HRNR STAT1 RIF1 KIF14 USP4 MTDH PCM1 | 1.29e-04 | 689 | 113 | 13 | int:TRIM21 |
| Interaction | AR interactions | TBX3 RNMT MYCBP2 ZMYND8 ITPRID2 HRNR HNRNPD NCOR1 RNASEL ZSCAN21 PHF3 TPX2 MORC3 PCM1 KNL1 SON | 1.31e-04 | 992 | 113 | 16 | int:AR |
| Interaction | PHF21A interactions | 1.36e-04 | 343 | 113 | 9 | int:PHF21A | |
| Interaction | ACTC1 interactions | WBP11 LRCH2 UFL1 HNRNPD STAT1 RIF1 PAPOLA PHF3 PPP4R2 TPX2 KIF14 HDGFL2 SON | 1.39e-04 | 694 | 113 | 13 | int:ACTC1 |
| Interaction | EXOSC4 interactions | 1.44e-04 | 202 | 113 | 7 | int:EXOSC4 | |
| Interaction | KPNA2 interactions | RNMT KAT6A UFL1 STAT1 PPP4R2 TPX2 KIF14 MORC3 ACBD3 HOMER2 SOS2 | 1.62e-04 | 519 | 113 | 11 | int:KPNA2 |
| Interaction | YWHAB interactions | MYCBP2 CEP162 KAT6A PSD3 APC PARD3B ITPRID2 CEP350 NEK1 PHF3 KIF14 USP4 ZCCHC7 MORC3 PCM1 SON | 1.68e-04 | 1014 | 113 | 16 | int:YWHAB |
| Interaction | CEBPA interactions | THOC1 WBP11 MYCBP2 CDKN2AIP ZMYND8 UBA2 RBM28 RFC1 HNRNPD STAT1 NCOR1 PSIP1 ZSCAN21 PPP4R2 TPX2 HDGFL2 PCM1 KNL1 | 1.90e-04 | 1245 | 113 | 18 | int:CEBPA |
| Interaction | XDH interactions | 2.12e-04 | 21 | 113 | 3 | int:XDH | |
| Interaction | HAPSTR1 interactions | THOC1 ZCCHC18 CASP8AP2 HSPA4L FSIP1 UBA2 UFL1 ITPRID2 SRFBP1 RIF1 MAGED2 KIF14 SPRED1 USP4 | 2.23e-04 | 829 | 113 | 14 | int:HAPSTR1 |
| Interaction | KDM1A interactions | CASP8AP2 ZNF280D MYCBP2 CEP162 ZMYND8 APC UBA2 CEP350 NCOR1 NEK1 ARHGAP29 KIF14 GOLGA5 PCM1 KNL1 | 2.45e-04 | 941 | 113 | 15 | int:KDM1A |
| Interaction | HDAC4 interactions | TBX3 HSPA4L PSD3 APC UFL1 STAT1 ITPR1 NCOR1 GPR158 SCN9A MTDH CCDC136 PCM1 | 2.74e-04 | 744 | 113 | 13 | int:HDAC4 |
| Interaction | FIP1L1 interactions | 2.79e-04 | 225 | 113 | 7 | int:FIP1L1 | |
| Interaction | GSK3A interactions | LRCH2 KIF21A APC STAT1 CEP350 NEK1 KIDINS220 MAGED2 ARHGAP29 PCM1 | 2.85e-04 | 464 | 113 | 10 | int:GSK3A |
| Interaction | CSNK1A1 interactions | 2.97e-04 | 381 | 113 | 9 | int:CSNK1A1 | |
| Interaction | CFAP184 interactions | 3.06e-04 | 162 | 113 | 6 | int:CFAP184 | |
| Interaction | TNFSF15 interactions | 3.08e-04 | 5 | 113 | 2 | int:TNFSF15 | |
| Interaction | PPP1CB interactions | WBP11 BMP2K MYCBP2 PPP1R9A ITPRID2 HNRNPD NCOR1 RIF1 PAPOLA KIF14 | 3.10e-04 | 469 | 113 | 10 | int:PPP1CB |
| Interaction | NR1H3 interactions | 3.15e-04 | 58 | 113 | 4 | int:NR1H3 | |
| Interaction | CEP120 interactions | 3.28e-04 | 106 | 113 | 5 | int:CEP120 | |
| Interaction | RBM8A interactions | 3.31e-04 | 473 | 113 | 10 | int:RBM8A | |
| Interaction | GRWD1 interactions | 3.53e-04 | 390 | 113 | 9 | int:GRWD1 | |
| Interaction | NDC80 interactions | 3.78e-04 | 312 | 113 | 8 | int:NDC80 | |
| Interaction | CDC42 interactions | LRCH2 CAMLG PPP1R9A PSD3 UFL1 STAT1 ITPR1 KIDINS220 EFNB1 PSIP1 TENM3 ARHGAP29 KIF14 GOLGA5 ACBD3 MTDH HOMER2 PCM1 | 3.97e-04 | 1323 | 113 | 18 | int:CDC42 |
| Interaction | DOCK5 interactions | 4.05e-04 | 111 | 113 | 5 | int:DOCK5 | |
| Interaction | MYO6 interactions | 4.09e-04 | 398 | 113 | 9 | int:MYO6 | |
| Interaction | POLR1G interactions | THOC1 WBP11 KAT6A ZMYND8 CHD2 RBM28 RFC1 SRFBP1 ZSCAN21 PHF3 | 4.30e-04 | 489 | 113 | 10 | int:POLR1G |
| Interaction | CDKL5 interactions | 4.40e-04 | 113 | 113 | 5 | int:CDKL5 | |
| Interaction | PPIA interactions | UIMC1 ZMYND8 CAST UBA2 UFL1 RFC1 RIF1 PSIP1 PHF3 KIF14 USP4 ACBD3 HDGFL2 KNL1 | 4.47e-04 | 888 | 113 | 14 | int:PPIA |
| Interaction | HDAC1 interactions | CASP8AP2 TBX3 MYCBP2 ZMYND8 APC RFC1 HNRNPD STAT1 NCOR1 NEK1 PAPOLA KIF14 GOLGA5 PCM1 KNL1 HR | 4.53e-04 | 1108 | 113 | 16 | int:HDAC1 |
| Interaction | SAFB interactions | 4.55e-04 | 244 | 113 | 7 | int:SAFB | |
| Interaction | CCDC177 interactions | 4.61e-04 | 6 | 113 | 2 | int:CCDC177 | |
| Interaction | H2BC12 interactions | 4.66e-04 | 322 | 113 | 8 | int:H2BC12 | |
| Interaction | H3C3 interactions | UIMC1 ZNF280D RFC1 RIF1 ZSCAN21 PHF3 TPX2 SCAF11 MORC3 HDGFL2 | 4.73e-04 | 495 | 113 | 10 | int:H3C3 |
| Interaction | DCTN1 interactions | MYCBP2 CEP162 APC UFL1 HNRNPD STAT1 CEP350 PPP4R2 KIF14 ACBD3 | 4.89e-04 | 497 | 113 | 10 | int:DCTN1 |
| Interaction | SUPT5H interactions | 4.89e-04 | 408 | 113 | 9 | int:SUPT5H | |
| Interaction | TSPYL1 interactions | 4.96e-04 | 116 | 113 | 5 | int:TSPYL1 | |
| Cytoband | 15q14 | 2.59e-04 | 49 | 115 | 3 | 15q14 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 6.67e-07 | 181 | 73 | 8 | 694 | |
| GeneFamily | PHD finger proteins | 3.14e-05 | 90 | 73 | 5 | 88 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 8.46e-04 | 46 | 73 | 3 | 622 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | CASP8AP2 RNMT SLF1 MYCBP2 HSPA4L CAST APC ZNF407 UFL1 RFC1 STAT1 ITPR1 CEP350 NEK1 RIF1 KIDINS220 PHF3 PPP4R2 KIF14 SCAF11 MTDH RAB27A PCM1 KNL1 SON | 8.95e-17 | 656 | 115 | 25 | M18979 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SECISBP2L PDE8A BMP2K MYCBP2 KAT6A ZMYND8 PSD3 APC ZNF804A ITPR1 CEP350 NEK1 RIF1 KIDINS220 UPF2 PHF3 ARHGAP29 KIF14 ACBD3 SON SOS2 | 1.42e-10 | 856 | 115 | 21 | M4500 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SLF1 MYCBP2 SUSD6 KAT6A ASH1L AKNA UBA2 CHD2 STAT1 ITPR1 CEP350 NCOR1 RIF1 KIDINS220 PSIP1 PAPOLA PHF3 SENP6 SCAF11 MTDH RAB27A PCM1 SON | 1.15e-07 | 1492 | 115 | 23 | M40023 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | SGSM1 MYCBP2 PPP1R9A ZMYND8 ASH1L RBM28 SCAF11 ZCCHC7 CCDC136 | 1.90e-07 | 193 | 115 | 9 | M6813 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | SGSM1 MYCBP2 PPP1R9A ZMYND8 ASH1L RBM28 SCAF11 ZCCHC7 CCDC136 | 2.16e-07 | 196 | 115 | 9 | MM667 |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | 7.42e-07 | 227 | 115 | 9 | M18441 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | RNMT MYCBP2 SUSD6 HSPA4L CAMLG KIF21A RTN4 DLGAP4 ASH1L PSD3 APC KIDINS220 PER3 PSIP1 GPR158 PDZRN3 PCM1 | 8.17e-07 | 946 | 115 | 17 | M39169 |
| Coexpression | PGF_UP.V1_UP | 2.01e-06 | 190 | 115 | 8 | M2674 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | SECISBP2L PDE8A MYCBP2 RTN4 CAST PSD3 STAT1 KIDINS220 PSIP1 UPF2 PHF3 MORC3 MTDH SOS2 | 2.65e-06 | 705 | 115 | 14 | M1410 |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | CAST APC CEP350 NCOR1 KIDINS220 UPF2 PHF3 ARHGAP29 SENP6 SON SOS2 | 3.08e-06 | 429 | 115 | 11 | M29 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | 7.28e-06 | 300 | 115 | 9 | M8702 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | SECISBP2L WBP11 RNMT RTN4 KAT6A CHD2 RFC1 HNRNPD RIF1 PSIP1 PHF3 PPP4R2 SON | 9.29e-06 | 680 | 115 | 13 | M41089 |
| Coexpression | GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP | 2.87e-05 | 199 | 115 | 7 | M5607 | |
| Coexpression | GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP | 2.96e-05 | 200 | 115 | 7 | M7831 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | PDE8A MYCBP2 KAT6A ZMYND8 ZNF804A CEP350 UPF2 PHF3 ARHGAP29 KIF14 | 4.04e-05 | 466 | 115 | 10 | M13522 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | SECISBP2L RNMT HSPA4L CDKN2AIP DLGAP4 PER3 UPF2 PHF3 SENP6 MORC3 GOLGA5 ACBD3 SOS2 | 6.64e-05 | 822 | 115 | 13 | M6782 |
| Coexpression | MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN | 7.57e-05 | 19 | 115 | 3 | M867 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | SECISBP2L WBP11 BMP2K ZMYND8 APC UBA2 RBM28 CEP350 PAPOLA UPF2 SCN9A SENP6 USP4 MTDH PCM1 SOS2 | 8.18e-05 | 1215 | 115 | 16 | M41122 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SECISBP2L TBX3 ASH1L CAST PSD3 PARD3B ITPRID2 STAT1 NCOR1 EFNB1 ARHGAP29 SON SOS2 | 9.74e-05 | 854 | 115 | 13 | M1533 |
| Coexpression | HEVNER_CORTEX_APICAL_AND_BASAL_INTERMEDIATE_PROGENITOR_CELLS | 1.01e-04 | 55 | 115 | 4 | MM397 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_3_DN | SLF1 KAT6A CAST MLLT10 SRFBP1 HNRNPD CEP350 RIF1 PER3 PSIP1 PPP4R2 ZCCHC7 MORC3 | 1.27e-04 | 877 | 115 | 13 | M2241 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | SECISBP2L TBX3 ASH1L CAST PSD3 PARD3B ITPRID2 STAT1 NCOR1 EFNB1 ARHGAP29 SON SOS2 | 1.43e-04 | 888 | 115 | 13 | MM1018 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 1.65e-04 | 184 | 115 | 6 | M9005 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | 2.05e-04 | 680 | 115 | 11 | MM456 | |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP | 2.05e-04 | 568 | 115 | 10 | M4023 | |
| Coexpression | VEGF_A_UP.V1_DN | 2.13e-04 | 193 | 115 | 6 | M2675 | |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_UP | 2.32e-04 | 196 | 115 | 6 | M4514 | |
| Coexpression | GSE3982_MAST_CELL_VS_TH2_UP | 2.45e-04 | 198 | 115 | 6 | M5455 | |
| Coexpression | GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP | 2.52e-04 | 199 | 115 | 6 | M7596 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP | 2.52e-04 | 199 | 115 | 6 | M8961 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.52e-04 | 199 | 115 | 6 | M5893 | |
| Coexpression | GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP | 2.52e-04 | 199 | 115 | 6 | M9596 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_UP | 2.58e-04 | 200 | 115 | 6 | M3378 | |
| Coexpression | GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP | 2.58e-04 | 200 | 115 | 6 | M5134 | |
| Coexpression | GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN | 2.58e-04 | 200 | 115 | 6 | M5986 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN | 2.58e-04 | 200 | 115 | 6 | M5005 | |
| Coexpression | GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP | 2.58e-04 | 200 | 115 | 6 | M5285 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 2.58e-04 | 200 | 115 | 6 | M7841 | |
| Coexpression | GSE24210_RESTING_TREG_VS_TCONV_UP | 2.58e-04 | 200 | 115 | 6 | M7839 | |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN | 2.58e-04 | 200 | 115 | 6 | M4979 | |
| Coexpression | GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN | 2.58e-04 | 200 | 115 | 6 | M7356 | |
| Coexpression | GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP | 2.58e-04 | 200 | 115 | 6 | M4355 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 2.76e-04 | 481 | 115 | 9 | M3898 | |
| Coexpression | KYNG_DNA_DAMAGE_UP | 2.95e-04 | 205 | 115 | 6 | M3961 | |
| Coexpression | MENON_FETAL_KIDNEY_4_PODOCYTES | 3.03e-04 | 206 | 115 | 6 | M39254 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | CAST APC ITPRID2 RFC1 RIF1 PAPOLA GPR158 TPX2 KIF14 ZCCHC7 KNL1 | 3.37e-04 | 721 | 115 | 11 | M10237 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL | 3.66e-04 | 300 | 115 | 7 | M45675 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 3.86e-04 | 399 | 115 | 8 | M40939 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 4.10e-04 | 79 | 115 | 4 | M7102 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | ZNF280D MYCBP2 CAMLG DLGAP4 KAT6A APC UBA2 ZNF407 CHD2 SRFBP1 NEK1 UPF2 PPP4R2 SPRED1 ACBD3 MTDH RAB27A PCM1 KNL1 | 1.03e-10 | 564 | 111 | 19 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ZNF280D KIF21A KAT6A APC UBA2 ZNF407 CHD2 SRFBP1 NEK1 RIF1 EFNB1 UPF2 ACBD3 HOMER2 RAB27A PCM1 KNL1 SON | 4.44e-09 | 629 | 111 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | THOC1 CASP8AP2 SLF1 LRCH2 ZNF280D KIF21A APC UFL1 RFC1 PCGF3 HNRNPD CEP350 RIF1 PSIP1 PAPOLA UPF2 PHF3 TPX2 SPRED1 SCAF11 MTDH PCM1 KNL1 | 1.15e-07 | 1257 | 111 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | THOC1 CASP8AP2 SLF1 LRCH2 ZNF280D HSPA4L KIF21A APC UFL1 RFC1 PCGF3 HNRNPD CEP350 RIF1 PSIP1 PAPOLA UPF2 PHF3 TPX2 SPRED1 SCAF11 MTDH PCM1 KNL1 | 4.11e-07 | 1459 | 111 | 24 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | ZCCHC18 CASP8AP2 SGSM1 ZNF280D HSPA4L CEP162 KIF21A DLGAP4 PSD3 APC CHGB MLLT10 RFC1 HNRNPD RNASEL PSIP1 PHF3 TPX2 KIF14 MTDH PCM1 KNL1 SOS2 | 5.28e-07 | 1370 | 111 | 23 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | ZNF280D KIF21A KAT6A APC ZNF407 CHD2 NEK1 EFNB1 UPF2 PPP4R2 SENP6 ACBD3 RAB27A SON | 2.73e-06 | 595 | 111 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 5.49e-06 | 311 | 111 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_1000 | TBX3 LRCH2 RTN4 CHGB NCOR1 NEK1 FBN2 RNASEL PSIP1 PPP4R2 NRK SPRED1 SPARCL1 PDZRN3 SOS2 | 1.58e-05 | 791 | 111 | 15 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | RBM44 USP45 ZNF280D ASH1L CHD2 RFC1 RIF1 RNASEL EFNB1 NRK ARHGAP29 SPRED1 SCAF11 ZCCHC7 MORC3 | 1.91e-05 | 804 | 111 | 15 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | CASP8AP2 WBP11 KIF21A RTN4 MLLT10 RIF1 PSIP1 PHF3 PPP4R2 TPX2 KIF14 SCAF11 | 2.24e-05 | 532 | 111 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | RNMT MYCBP2 PPP1R9A APC ITPR1 CEP350 PER3 PAPOLA PHF3 ZCCHC7 | 2.77e-05 | 375 | 111 | 10 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.46e-05 | 385 | 111 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | USP45 PSD3 HNRNPD NCOR1 NEK1 RIF1 FBN2 PSIP1 PAPOLA SON SOS2 | 4.19e-05 | 478 | 111 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000_k5 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.37e-05 | 179 | 111 | 7 | gudmap_developingGonad_e14.5_ ovary_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#5_top-relative-expression-ranked_1000 | USP45 CDKN2AIP PSD3 HNRNPD NCOR1 RIF1 FBN2 PSIP1 HOMER2 SON SOS2 | 5.44e-05 | 492 | 111 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000_k5 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | SLF1 LRCH2 BMP2K PSD3 RFC1 ITPR1 FBN2 RNASEL EFNB1 TENM3 NRK GPC4 ARHGAP29 SPARCL1 | 5.86e-05 | 783 | 111 | 14 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | THOC1 CASP8AP2 PDE8A LRCH2 ZNF280D KIF21A APC UFL1 RFC1 PCGF3 RIF1 RNASEL PSIP1 TPX2 SPRED1 PDZRN3 PCM1 KNL1 | 8.39e-05 | 1252 | 111 | 18 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.02e-04 | 354 | 111 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.08e-04 | 278 | 111 | 8 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | TBX3 SLF1 PSD3 CEP350 FBN2 RNASEL EFNB1 TENM3 NRK TPX2 ARHGAP29 KIF14 SPARCL1 PDZRN3 | 1.10e-04 | 831 | 111 | 14 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | TBX3 USP45 CDKN2AIP KIF21A PSD3 HNRNPD NCOR1 RIF1 FBN2 PSIP1 NRK HOMER2 SON SOS2 | 1.17e-04 | 836 | 111 | 14 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | LRCH2 BMP2K PSD3 ITPR1 CEP350 FBN2 RNASEL TENM3 MAGED2 NRK GPC4 ARHGAP29 SPARCL1 | 1.31e-04 | 740 | 111 | 13 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_500 | 2.03e-04 | 388 | 111 | 9 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | USP45 SLF1 ZNF280D CEP162 KIF21A ASH1L CHD2 PCGF3 TPX2 SCAF11 ZCCHC7 GOLGA5 ACBD3 | 2.19e-04 | 780 | 111 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | RBM44 ASH1L CHD2 CHGB RFC1 RIF1 RNASEL EFNB1 PAPOLA NRK SPRED1 SCAF11 KNL1 | 3.00e-04 | 806 | 111 | 13 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_k-means-cluster#4_top-relative-expression-ranked_500 | 3.22e-04 | 247 | 111 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.45e-04 | 330 | 111 | 8 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | TBX3 MYCBP2 KIF21A ASH1L APC CHGB ZNF804A HNRNPD CEP350 NEK1 RIF1 PHF3 NRK | 3.46e-04 | 818 | 111 | 13 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | TBX3 MYCBP2 PPP1R9A APC CHGB ZNF804A CEP350 NEK1 FBN2 PHF3 NRK MTDH SON | 3.46e-04 | 818 | 111 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | THOC1 PDE8A LRCH2 ZNF280D CAMLG PPP1R9A PSD3 FBN2 RNASEL MAGED2 ZSCAN21 NRK SENP6 SPRED1 SPARCL1 PDZRN3 | 3.65e-04 | 1166 | 111 | 16 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500 | CASP8AP2 SLF1 LRCH2 ZNF280D HSPA4L CEP162 KIF21A APC CHGB PCGF3 ZNF804A RIF1 RNASEL PSIP1 TPX2 KIF14 PCM1 KNL1 | 3.78e-04 | 1414 | 111 | 18 | facebase_RNAseq_e10.5_Emin_MedNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | CASP8AP2 SLF1 CEP162 KIF21A ASH1L CHD2 PCGF3 NCOR1 NEK1 RIF1 TPX2 PCM1 KNL1 | 4.02e-04 | 831 | 111 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | CASP8AP2 SLF1 LRCH2 ZNF280D CEP162 KIF21A APC PCGF3 RIF1 RNASEL PSIP1 TPX2 KIF14 PCM1 KNL1 | 4.10e-04 | 1060 | 111 | 15 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#3_top-relative-expression-ranked_500 | 4.55e-04 | 122 | 111 | 5 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k3_500 | |
| CoexpressionAtlas | kidney_e10.5_UretericTip_HoxB7_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.90e-04 | 348 | 111 | 8 | gudmap_kidney_e10.5_UretericTip_HoxB7_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_1000 | TBX3 USP45 PSD3 HNRNPD NCOR1 NEK1 RIF1 FBN2 PSIP1 PAPOLA HOMER2 SON SOS2 | 4.97e-04 | 850 | 111 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | 5.61e-04 | 271 | 111 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_1000_K3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_500 | 5.80e-04 | 357 | 111 | 8 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_500 | |
| CoexpressionAtlas | e10.5_NeuroEpith_LateralEmin_top-relative-expression-ranked_100 | 5.83e-04 | 73 | 111 | 4 | Facebase_ST1_e10.5_NeuroEpith_LateralEmin_100 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k-means-cluster#2_top-relative-expression-ranked_500 | 5.87e-04 | 129 | 111 | 5 | gudmap_dev lower uro neuro_e15.5_BladdPelvicGanglion_Sox10_k2_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.98e-04 | 203 | 111 | 6 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | THOC1 CASP8AP2 SLF1 PDE8A LRCH2 ZNF280D APC PCGF3 RIF1 PSIP1 ZSCAN21 NRK TPX2 SCAF11 PCM1 KNL1 | 7.19e-04 | 1241 | 111 | 16 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | RBM44 HSPA4L ASH1L CHD2 RFC1 RIF1 RNASEL PER3 ARHGAP29 SPRED1 SCAF11 ZCCHC7 | 7.67e-04 | 778 | 111 | 12 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | ZCCHC18 CASP8AP2 SGSM1 HSPA4L KIF21A PPP1R9A PSD3 CEP350 TPX2 GPC4 SCN9A HOMER2 CCDC136 | 7.87e-04 | 893 | 111 | 13 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | 8.01e-04 | 469 | 111 | 9 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 8.55e-04 | 379 | 111 | 8 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | ASH1L PARD3B CHD2 RFC1 RIF1 FBN2 RNASEL EFNB1 NRK SPRED1 SCAF11 KNL1 | 8.76e-04 | 790 | 111 | 12 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | ZCCHC18 CASP8AP2 PPP1R9A PSD3 AKNA CHD2 CEP350 GPC4 HOMER2 CCDC136 PCM1 | 9.58e-04 | 688 | 111 | 11 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5 |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500 | 9.94e-04 | 388 | 111 | 8 | gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 1.02e-03 | 146 | 111 | 5 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500 | |
| CoexpressionAtlas | e10.5_NeuroEpith_FlankLateral_top-relative-expression-ranked_500 | 1.11e-03 | 395 | 111 | 8 | Facebase_ST1_e10.5_NeuroEpith_FlankLateral_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#2 | 1.11e-03 | 395 | 111 | 8 | Facebase_RNAseq_e8.5_Floor Plate_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.16e-03 | 150 | 111 | 5 | gudmap_developingGonad_e12.5_ovary_k4_1000 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SECISBP2L BMP2K HSPA4L PPP1R9A ASH1L CAST CEP350 NCOR1 RNASEL PHF3 SENP6 SCAF11 MTDH | 3.22e-15 | 191 | 115 | 13 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SECISBP2L BMP2K HSPA4L PPP1R9A ASH1L CAST CEP350 NCOR1 RNASEL PHF3 SENP6 SCAF11 MTDH | 3.22e-15 | 191 | 115 | 13 | 09db184cb90fe282a14474d7217068c58092c6f8 |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SECISBP2L BMP2K HSPA4L PPP1R9A ASH1L CAST CEP350 NCOR1 RNASEL PHF3 SENP6 SCAF11 MTDH | 3.22e-15 | 191 | 115 | 13 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | RNMT MYCBP2 ASH1L CAST CHD2 STAT1 CEP350 PHF3 SCAF11 PCM1 SON | 4.83e-12 | 200 | 115 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-09 | 184 | 115 | 9 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-09 | 195 | 115 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.10e-08 | 187 | 115 | 8 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.29e-08 | 195 | 115 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.22e-08 | 200 | 115 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.12e-07 | 178 | 115 | 7 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-07 | 182 | 115 | 7 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.54e-07 | 186 | 115 | 7 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.95e-07 | 188 | 115 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.86e-07 | 192 | 115 | 7 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.10e-07 | 193 | 115 | 7 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 9.02e-07 | 200 | 115 | 7 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.02e-07 | 200 | 115 | 7 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 183 | 115 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 183 | 115 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.38e-06 | 184 | 115 | 6 | a8c6028d745aaa6ee7842259238694cb50ce0526 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.38e-06 | 184 | 115 | 6 | 081d045f3bc98a36f342de7d50f39c9a888dd7eb | |
| ToppCell | Control-Myeloid_G-immature_Neutrophil|Control / Disease group, lineage and cell class | 8.38e-06 | 184 | 115 | 6 | 45f873236f7e90fb78c8e291d3b5b92d121acec9 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.38e-06 | 184 | 115 | 6 | 84c20730cd92b9aaa50077d7b625e37e7f9e91d2 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.38e-06 | 184 | 115 | 6 | d31d4116d1d196633784863781fa45673607a421 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 8.65e-06 | 185 | 115 | 6 | 857c7ca8493e91ef1d0078ddafd6082020f9b169 | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.19e-06 | 187 | 115 | 6 | 14c239af77116d28d511dea754b6150d20488080 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-05 | 193 | 115 | 6 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-05 | 193 | 115 | 6 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_aerocyte_capillary-EC_aerocyte_capillary_L.2.0.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-05 | 193 | 115 | 6 | aaf681f16f310168e4719464814a1fc0a2f8431a | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 195 | 115 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | COVID-19_Severe-PLT_4|World / Disease Group and Platelet Clusters | 1.20e-05 | 196 | 115 | 6 | ad43efdd4d73b6615f65f06a315b33576e317473 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-05 | 198 | 115 | 6 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | COVID-19_Severe-PLT_4|COVID-19_Severe / Disease Group and Platelet Clusters | 1.27e-05 | 198 | 115 | 6 | abfddbee99ef8c7719e6e6f62571e9be030e4acf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2|World / Primary Cells by Cluster | 1.31e-05 | 199 | 115 | 6 | f09b40245d3d826275bbe5f508dedccc75a911bd | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.31e-05 | 199 | 115 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV|World / Primary Cells by Cluster | 1.31e-05 | 199 | 115 | 6 | e45448ec4db8875c8aaa9aad109a10e2905a4226 | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.31e-05 | 199 | 115 | 6 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 115 | 6 | 2cc98abf11f5b58707de45a2282f03d47f00f035 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | edb64556b3fefe3144f73b6efe23b9ffd34091d2 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | b7533c571eeea0cb3678e1a57d3dc036fa8d0f49 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport|Brain_organoid / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 115 | 6 | b0ba486b55be18a4236bd2644f02352651f4b1fe | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuroepithelial-Proteoglycan-expressing_cell|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.35e-05 | 200 | 115 | 6 | 0f7431f670f3a175377cefae3479403a881bb8fb | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 1.35e-05 | 200 | 115 | 6 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.35e-05 | 200 | 115 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.81e-05 | 159 | 115 | 5 | f34f2729a3872fbb2939e76ad35d7e25f71b8f57 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Mesenchymal-Unfolded_protein_responsible_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 5.81e-05 | 159 | 115 | 5 | 929ed98f6c2ad14e8d5af5c6f11a5a3d4b388cf7 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.53e-05 | 163 | 115 | 5 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.53e-05 | 163 | 115 | 5 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.97e-05 | 170 | 115 | 5 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.19e-05 | 171 | 115 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.13e-05 | 175 | 115 | 5 | 284fdc7a9d303636a637041846850d19d114861a | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 9.13e-05 | 175 | 115 | 5 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.13e-05 | 175 | 115 | 5 | 19eda8b5d39dc93d79737ebdbeeba5ec0cb23c51 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 179 | 115 | 5 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.02e-04 | 179 | 115 | 5 | f2e8fc975c30992611630197b79daaeef7c4211d | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 179 | 115 | 5 | ce3ca7f3a5864e62307aa744a3173f350a90df28 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 115 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 1.13e-04 | 183 | 115 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-Glial_immature-cycling_ENCC/glia|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 183 | 115 | 5 | 29b62dd542bc3f8df843998f577724f3818d4271 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 183 | 115 | 5 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.13e-04 | 183 | 115 | 5 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 184 | 115 | 5 | 3e5c68a99c10eb1ddc1048bea4aa9f6b8e2746ff | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.16e-04 | 184 | 115 | 5 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-04 | 184 | 115 | 5 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-immature_Neutrophil-|Control / Disease condition and Cell class | 1.16e-04 | 184 | 115 | 5 | c4e8ba82a6aa76c46f05a71d5f1c7926555318cf | |
| ToppCell | Control-immature_Neutrophil|Control / Disease condition and Cell class | 1.16e-04 | 184 | 115 | 5 | 2fdae5c6b3eb2232881d933a8c1061fda3623016 | |
| ToppCell | PND07-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 184 | 115 | 5 | 1e2f0cec50475a1cf2973a5082826bbc60fc9a68 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 185 | 115 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-actively_dividing_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | 9feef5936985e936b3d88f9d1bb012abb6468570 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 186 | 115 | 5 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | f5468e03321ea2083e223eb0d92c3a9307039569 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.22e-04 | 186 | 115 | 5 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial-keratinocyte_stem_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.22e-04 | 186 | 115 | 5 | 89f5b06bc56674af304912d481ac697c7c870904 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 187 | 115 | 5 | ea9d34bcd3bd1f36745846309ede349773de501a | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.25e-04 | 187 | 115 | 5 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Degenerative_Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-04 | 187 | 115 | 5 | c31130fc2f9f882944b2ba366a034a03f051c4b9 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 188 | 115 | 5 | b21e93a70583c30d05c0833cd3d4d4bca44a039e | |
| ToppCell | Epithelial-Epithelial-D_(Ciliated)|Epithelial / shred on cell class and cell subclass (v4) | 1.28e-04 | 188 | 115 | 5 | 8f30535a32968a81a304315a49c0d90a77d36948 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A3_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-04 | 188 | 115 | 5 | bd091503f580dedab40e0996273101285d24b586 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 1.28e-04 | 188 | 115 | 5 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 188 | 115 | 5 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-04 | 188 | 115 | 5 | 874404a4fd9aa42873f6c53dc42da22d3b0fdb9e | |
| ToppCell | E12.5-Mesenchymal|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.28e-04 | 188 | 115 | 5 | 9778dadc2bd7ded3a723e717d1c8cd3160e99c6c | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 1.31e-04 | 189 | 115 | 5 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 189 | 115 | 5 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-04 | 189 | 115 | 5 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 190 | 115 | 5 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo|lymph-node_spleen / Manually curated celltypes from each tissue | 1.34e-04 | 190 | 115 | 5 | 4225bfa10a6fb909a3ba8ac26f3541c390b46737 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-04 | 190 | 115 | 5 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 190 | 115 | 5 | b99271d139c8d01e20feb95d99f79c9b2756b4cb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 190 | 115 | 5 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 190 | 115 | 5 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-04 | 190 | 115 | 5 | ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2 | |
| ToppCell | facs-Pancreas-Endocrine-3m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-04 | 191 | 115 | 5 | b3de0393d6510543533cd851e47a0f95739a0e4e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-04 | 191 | 115 | 5 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.38e-04 | 191 | 115 | 5 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.13e-07 | 50 | 69 | 6 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.65e-04 | 49 | 69 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Drug | Pramoxine hydrochloride [637-58-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.82e-07 | 192 | 115 | 9 | 6054_DN | |
| Drug | Cefotaxime sodium salt [64485-93-4]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 7.22e-07 | 197 | 115 | 9 | 2235_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.46e-06 | 178 | 115 | 8 | 3998_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 5.39e-06 | 189 | 115 | 8 | 4271_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 5.60e-06 | 190 | 115 | 8 | 7070_UP | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 5.82e-06 | 191 | 115 | 8 | 4283_DN | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 6.05e-06 | 192 | 115 | 8 | 4110_DN | |
| Drug | Homatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; PC3; HT_HG-U133A | 6.05e-06 | 192 | 115 | 8 | 5058_DN | |
| Drug | Eucatropine hydrochloride [536-93-6]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 6.29e-06 | 193 | 115 | 8 | 3841_DN | |
| Drug | pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A | 6.29e-06 | 193 | 115 | 8 | 6893_UP | |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | 6.78e-06 | 195 | 115 | 8 | 2122_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 7.04e-06 | 196 | 115 | 8 | 3965_DN | |
| Drug | Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; MCF7; HT_HG-U133A | 7.04e-06 | 196 | 115 | 8 | 2229_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 7.59e-06 | 198 | 115 | 8 | 2217_DN | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; MCF7; HT_HG-U133A | 7.59e-06 | 198 | 115 | 8 | 5611_DN | |
| Drug | Iodipamide [606-17-7]; Down 200; 3.6uM; MCF7; HT_HG-U133A | 7.87e-06 | 199 | 115 | 8 | 6490_DN | |
| Drug | Clorgyline | 2.36e-05 | 168 | 115 | 7 | ctd:D003010 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 2.45e-05 | 169 | 115 | 7 | 1056_UP | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 4.08e-05 | 183 | 115 | 7 | 1206_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 4.37e-05 | 185 | 115 | 7 | 831_UP | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.84e-05 | 188 | 115 | 7 | 6735_DN | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | 5.00e-05 | 189 | 115 | 7 | 1288_DN | |
| Drug | Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 5.35e-05 | 191 | 115 | 7 | 4279_DN | |
| Drug | Terfenadine [50679-08-8]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 5.35e-05 | 191 | 115 | 7 | 2227_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; HL60; HT_HG-U133A | 5.53e-05 | 192 | 115 | 7 | 1271_DN | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 5.53e-05 | 192 | 115 | 7 | 4104_DN | |
| Drug | N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A | 5.53e-05 | 192 | 115 | 7 | 4311_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 5.71e-05 | 193 | 115 | 7 | 4690_DN | |
| Drug | Mefloquine hydrochloride [51773-92-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 5.71e-05 | 193 | 115 | 7 | 6205_DN | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 5.90e-05 | 194 | 115 | 7 | 4134_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 5.90e-05 | 194 | 115 | 7 | 7481_DN | |
| Drug | Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A | 5.90e-05 | 194 | 115 | 7 | 2824_DN | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; HL60; HG-U133A | 5.90e-05 | 194 | 115 | 7 | 1715_DN | |
| Drug | calmidazolium chloride; Down 200; 5uM; MCF7; HT_HG-U133A_EA | 5.90e-05 | 194 | 115 | 7 | 906_DN | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 5.90e-05 | 194 | 115 | 7 | 4361_DN | |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 5.90e-05 | 194 | 115 | 7 | 2238_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 6.09e-05 | 195 | 115 | 7 | 3710_DN | |
| Drug | PNU-0230031 [267429-39-0]; Down 200; 10uM; PC3; HT_HG-U133A | 6.09e-05 | 195 | 115 | 7 | 3732_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 6.29e-05 | 196 | 115 | 7 | 5230_UP | |
| Drug | Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.29e-05 | 196 | 115 | 7 | 5411_DN | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 6.29e-05 | 196 | 115 | 7 | 7228_DN | |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A | 6.29e-05 | 196 | 115 | 7 | 5679_DN | |
| Drug | Phenylpropanolamine hydrochloride [154-41-6]; Down 200; 21.4uM; MCF7; HT_HG-U133A | 6.29e-05 | 196 | 115 | 7 | 3217_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; PC3; HT_HG-U133A | 6.29e-05 | 196 | 115 | 7 | 4683_DN | |
| Drug | 9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; MCF7; HT_HG-U133A | 6.29e-05 | 196 | 115 | 7 | 7552_UP | |
| Drug | Zlllal | HSPA4L CAST UBA2 HNRNPD STAT1 ITPR1 NCOR1 PSIP1 NRK TPX2 SENP6 SPRED1 | 6.44e-05 | 613 | 115 | 12 | CID000107707 |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 2559_DN | |
| Drug | estradiol, USP; Down 200; 0.1uM; PC3; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 1208_DN | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 1543_UP | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 2860_DN | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 3338_DN | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 6792_DN | |
| Drug | Clorsulon [60200-06-8]; Up 200; 10.6uM; PC3; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 7264_UP | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 6.50e-05 | 197 | 115 | 7 | 7434_DN | |
| Drug | Betonicine [515-25-3]; Up 200; 25.2uM; PC3; HT_HG-U133A | 6.71e-05 | 198 | 115 | 7 | 4301_UP | |
| Drug | vinblastine sulfate; Down 200; 0.1uM; MCF7; HT_HG-U133A | 6.71e-05 | 198 | 115 | 7 | 7517_DN | |
| Drug | Urosiol [128-13-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 6.71e-05 | 198 | 115 | 7 | 7243_UP | |
| Drug | 5253409; Down 200; 17uM; MCF7; HT_HG-U133A_EA | 6.71e-05 | 198 | 115 | 7 | 961_DN | |
| Drug | Evoxine [522-11-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.71e-05 | 198 | 115 | 7 | 4704_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 6.71e-05 | 198 | 115 | 7 | 5621_DN | |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 6.71e-05 | 198 | 115 | 7 | 1061_DN | |
| Drug | Hydroxytacrine maleate (R,S) [118909-22-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 6.71e-05 | 198 | 115 | 7 | 3292_DN | |
| Drug | 5248896; Down 200; 11uM; MCF7; HT_HG-U133A_EA | 6.71e-05 | 198 | 115 | 7 | 955_DN | |
| Drug | L(-)-vesamicol hydrochloride [112709-59-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 6.71e-05 | 198 | 115 | 7 | 5056_DN | |
| Drug | Antipyrine [60-80-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 6.71e-05 | 198 | 115 | 7 | 1489_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 6.71e-05 | 198 | 115 | 7 | 3707_DN | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 6.93e-05 | 199 | 115 | 7 | 4352_DN | |
| Drug | Nomifensine maleate [32795-47-4]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 6.93e-05 | 199 | 115 | 7 | 2224_DN | |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A | 6.93e-05 | 199 | 115 | 7 | 5617_DN | |
| Drug | Repaglinide [135062-02-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 6.93e-05 | 199 | 115 | 7 | 3558_DN | |
| Drug | Etodolac [41340-25-4]; Up 200; 14uM; PC3; HT_HG-U133A | 6.93e-05 | 199 | 115 | 7 | 7246_UP | |
| Drug | PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A | 6.93e-05 | 199 | 115 | 7 | 4562_DN | |
| Drug | Methylatropine nitrate [52-88-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 6.93e-05 | 199 | 115 | 7 | 6495_DN | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; PC3; HT_HG-U133A | 7.15e-05 | 200 | 115 | 7 | 6612_DN | |
| Drug | AC1L3BEB | 8.11e-05 | 17 | 115 | 3 | CID000086370 | |
| Drug | bromfenacoum | SGSM1 HSPA4L CDKN2AIP KIF21A RTN4 PPP1R9A CAST APC HNRNPD PSIP1 USP4 CCDC136 | 1.03e-04 | 644 | 115 | 12 | ctd:C013418 |
| Drug | Succimer | THOC1 CASP8AP2 SLF1 ZNF280D RTN4 TRPC5 ZMYND8 ASH1L CAST MLLT10 ZNF804A ITPR1 RIF1 UPF2 PHF3 ZCCHC7 PCM1 | 2.03e-04 | 1264 | 115 | 17 | ctd:D004113 |
| Drug | Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A | 2.58e-04 | 174 | 115 | 6 | 1302_UP | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.83e-04 | 177 | 115 | 6 | 985_DN | |
| Drug | Proscillaridin A [466-06-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 3.01e-04 | 179 | 115 | 6 | 4404_DN | |
| Drug | Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A | 3.01e-04 | 179 | 115 | 6 | 4585_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.10e-04 | 180 | 115 | 6 | 4541_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.29e-04 | 182 | 115 | 6 | 3887_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.39e-04 | 183 | 115 | 6 | 7498_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.49e-04 | 184 | 115 | 6 | 2321_DN | |
| Drug | 17-AAG; Up 200; 1uM; PC3; HT_HG-U133A | 3.80e-04 | 187 | 115 | 6 | 1218_UP | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 3.91e-04 | 188 | 115 | 6 | 5116_DN | |
| Drug | radicicol; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.02e-04 | 189 | 115 | 6 | 836_UP | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 4.02e-04 | 189 | 115 | 6 | 2041_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 4.02e-04 | 189 | 115 | 6 | 6649_DN | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; PC3; HT_HG-U133A | 4.02e-04 | 189 | 115 | 6 | 6895_UP | |
| Drug | Resveratrol [501-36-0]; Down 200; 17.6uM; PC3; HT_HG-U133A | 4.02e-04 | 189 | 115 | 6 | 5084_DN | |
| Drug | Ampyrone [83-07-8]; Down 200; 19.6uM; PC3; HT_HG-U133A | 4.13e-04 | 190 | 115 | 6 | 4507_DN | |
| Drug | Luteolin [491-70-3]; Down 200; 14uM; HL60; HT_HG-U133A | 4.13e-04 | 190 | 115 | 6 | 3041_DN | |
| Drug | Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A | 4.13e-04 | 190 | 115 | 6 | 4306_DN | |
| Drug | Pempidine tartrate [546-48-5]; Down 200; 13uM; PC3; HT_HG-U133A | 4.13e-04 | 190 | 115 | 6 | 4307_DN | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.13e-04 | 190 | 115 | 6 | 952_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 4.25e-04 | 191 | 115 | 6 | 6020_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 4.25e-04 | 191 | 115 | 6 | 6644_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 4.37e-04 | 192 | 115 | 6 | 4268_DN | |
| Disease | serum IgG glycosylation measurement | CAST ZNF407 CHD2 ZNF804A TENM3 GPR158 PROX2 ARHGAP29 GOLGA5 SOS2 | 2.70e-05 | 523 | 110 | 10 | EFO_0005193 |
| Disease | SPARC-like protein 1 measurement | 2.05e-04 | 6 | 110 | 2 | EFO_0008289 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.69e-04 | 152 | 110 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Neurodevelopmental Disorders | 4.14e-04 | 93 | 110 | 4 | C1535926 | |
| Disease | heel bone mineral density, urate measurement | 6.13e-04 | 182 | 110 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | Myoclonic Astatic Epilepsy | 7.41e-04 | 11 | 110 | 2 | C0393702 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 8.20e-04 | 49 | 110 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | healthspan | 1.05e-03 | 13 | 110 | 2 | EFO_0009762 | |
| Disease | Colorectal Carcinoma | 1.27e-03 | 702 | 110 | 9 | C0009402 | |
| Disease | glycerol-3-phosphate measurement | 1.40e-03 | 15 | 110 | 2 | EFO_0010488 | |
| Disease | idiopathic dilated cardiomyopathy | 1.48e-03 | 60 | 110 | 3 | EFO_0009094 | |
| Disease | primary autosomal recessive microcephaly (is_implicated_in) | 1.60e-03 | 16 | 110 | 2 | DOID:0070296 (is_implicated_in) | |
| Disease | C-reactive protein measurement | RNMT BAAT CAST SPPL3 PSD3 CCDC168 MLLT10 ITPR1 NCOR1 PAPOLA SCAF11 ZCCHC7 | 1.82e-03 | 1206 | 110 | 12 | EFO_0004458 |
| Disease | disease free survival | 2.03e-03 | 18 | 110 | 2 | EFO_0000409 | |
| Disease | aspartate aminotransferase measurement | ANKRD31 KIF27 CDKN2AIP CAST SPPL3 AKNA MLLT10 ITPR1 ARHGAP29 SOS2 | 2.06e-03 | 904 | 110 | 10 | EFO_0004736 |
| Disease | Prostatic Neoplasms | 2.19e-03 | 616 | 110 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 2.19e-03 | 616 | 110 | 8 | C0376358 | |
| Disease | cystathionine measurement | 2.26e-03 | 19 | 110 | 2 | EFO_0010474 | |
| Disease | body weight | SECISBP2L DSPP CAST PARD3B MLLT10 ITPR1 NCOR1 FBN2 PHF3 RRH SENP6 PCM1 | 2.62e-03 | 1261 | 110 | 12 | EFO_0004338 |
| Disease | Autosomal Recessive Primary Microcephaly | 3.03e-03 | 22 | 110 | 2 | C3711387 | |
| Disease | anxiety disorder (implicated_via_orthology) | 3.03e-03 | 22 | 110 | 2 | DOID:2030 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KHEGDVQEEQKTHTT | 306 | Q6N043 | |
| GAEEESQTKSKQQDS | 56 | P49069 | |
| KSSDRQGSDEESVHS | 11 | Q9NTU4 | |
| EGDKTINSKAHAEQA | 326 | Q14032 | |
| DSSETSVSEKENGHE | 2566 | Q9NR48 | |
| ANVSEGEKKTEESSQ | 2891 | Q9NR48 | |
| KVSVDLGSDSEHTKQ | 751 | Q8NDM7 | |
| LGSDSEHTKQKASTD | 756 | Q8NDM7 | |
| EHTKQKASTDLSQDE | 761 | Q8NDM7 | |
| DSNKKSHIALGTESE | 4161 | Q86UQ4 | |
| GKEDDHDSSIGQNSD | 286 | Q9NZW4 | |
| EKKAEHSSINQENGT | 691 | Q9NSY1 | |
| KNEGSSIEDAQTSQH | 1266 | Q9UKL3 | |
| SNKNVDGSKSTHEEQ | 1601 | Q9UKL3 | |
| DSQDHKSEVTSQSGL | 591 | Q9Y2H0 | |
| SNGHASTDQLSEEKE | 201 | P51159 | |
| KDTQSVSAIGEEKSH | 196 | Q9NW13 | |
| DTATILSNQHEKDSG | 556 | Q9UPQ7 | |
| SAEDTQKHDTDEDSQ | 171 | Q6ZP01 | |
| SHRNGETKADDSSNK | 121 | Q3KNV8 | |
| DSKNEDGSVFSQTEH | 11 | O14718 | |
| SDENVAKLDHNTTTE | 366 | Q9UPP5 | |
| DDGKTIDSSSLSHQE | 1306 | Q8N7Z5 | |
| DESKVHSLAGQKSES | 716 | Q8TEW8 | |
| TKEEHQQSKSSGIDG | 1601 | Q15058 | |
| SIHSNLEQEKGKDSE | 1426 | Q9ULH0 | |
| KHLDGEEDGSSDQSQ | 181 | Q9UNF1 | |
| GTNDSQHSKCDVDKS | 966 | Q96PY6 | |
| EEGNNKPQKHESTSS | 1166 | Q14643 | |
| TDHAGKSANEKADSA | 516 | O75487 | |
| QIGHQEKKTSSSEEN | 1136 | Q5T848 | |
| NSDSSHEGQEESSKE | 186 | Q8TBA6 | |
| HEGQEESSKENVSSN | 191 | Q8TBA6 | |
| ASSVNGTDDEKASHA | 141 | Q9NSB8 | |
| DSDTDVKSHAAGSKQ | 61 | Q9GZP8 | |
| IEGKNSSAVEQDHAK | 146 | Q9NXV6 | |
| DTSIGNKDVDSGQHD | 451 | O43593 | |
| NKTETDDNQFTKSHS | 1321 | Q86VH2 | |
| ESHEKGENVKSVNSG | 1436 | Q15154 | |
| TSSSSEEDKQNHKAD | 566 | P56645 | |
| AKIHETQETTDKSAD | 676 | Q14149 | |
| SDTHTDNQTGKHKDR | 341 | O60658 | |
| NQSKQGESEKHIFTE | 76 | Q96JB1 | |
| EKEENKRQESSFSHS | 116 | Q86YZ3 | |
| DEENKKSHNGAETTS | 1646 | Q8NG31 | |
| GQAKTHTDSSEKELE | 336 | Q9H3P7 | |
| TENEQSKETQSHESK | 391 | P28290 | |
| SKETQSHESKLGEES | 396 | P28290 | |
| ATSQKGESAEDKEHE | 606 | Q7Z4V5 | |
| SGHDKTEAKEQLDTE | 681 | P51003 | |
| TSKDLSGAEKHQESE | 196 | Q3B8N5 | |
| ISVGKSVSHENKEQD | 811 | Q92794 | |
| NSTEEEKVDGNVNKH | 471 | Q52LW3 | |
| SQEGSTDHKEALLSN | 106 | Q96BT1 | |
| GQDESVDSKKSTSHD | 316 | Q9P296 | |
| DKSQEEDSSLHSNAS | 6 | O14647 | |
| SLGDSDGKHETVNQE | 201 | P98172 | |
| HSDDDTKDNKATSPG | 1806 | Q5VT06 | |
| EQASGDKLSEHSEVN | 176 | Q7Z591 | |
| HSLGDEDKQKIESNT | 301 | Q5TB80 | |
| SDTGSNDAHNKKAVS | 71 | P20810 | |
| EKQKNLEEGHSSTVA | 136 | O43148 | |
| SDAKAVQNSSRHDGK | 171 | Q86UE4 | |
| SGKEDHSESSNTENR | 51 | Q8NA03 | |
| EAGKDKDLQSTSADH | 396 | Q86VF2 | |
| SHQKSSEAGEKADGV | 4121 | Q8NDH2 | |
| SGDLEEKHQTDANTN | 5931 | Q8NDH2 | |
| GHKQSETTQKCEDID | 306 | P35556 | |
| HTGSDVEQDAEKKAT | 441 | Q9ULU4 | |
| HTQEGEEKKQTSGTS | 291 | Q99590 | |
| QEKTHSREKSSQESG | 226 | P05060 | |
| QNEEKNHSDSSTSES | 206 | Q9NY27 | |
| NDSHIIGSKTDSQKD | 386 | Q5VUJ6 | |
| QEQEDEEASTGSHLK | 551 | Q9HAU5 | |
| DHESDNKDISESSTQ | 1126 | Q7Z2Y5 | |
| AKIDASKNEEDEGHS | 66 | Q14103 | |
| ADSLEQTNHEKDSES | 426 | Q9NQC3 | |
| QTNHEKDSESSNDDT | 431 | Q9NQC3 | |
| DHDASNSKGNMKSDD | 1156 | Q07890 | |
| EHETNGVAKSDQKQE | 181 | P42224 | |
| DERHKKENGTSDESS | 326 | O15119 | |
| QDVASEHSNSKGEET | 356 | P0C2Y1 | |
| ESSKESQQHSKSSAD | 291 | P35251 | |
| ESTTESQDKENSHQK | 1426 | Q5UIP0 | |
| NHASKVEGDNTKERD | 831 | O75376 | |
| QEHIEINDTDSDGKT | 261 | Q05823 | |
| DKATSDDSGTTNQIH | 651 | Q15858 | |
| HDSDEKDLSSQETGL | 51 | P0DL12 | |
| ISSEEGETEANNHKK | 491 | Q9UBT2 | |
| SENEKEVSCKHSTSE | 891 | Q93073 | |
| HINNILSKSDDGDSE | 3701 | O75592 | |
| HKETADSENSDIQSL | 271 | Q92537 | |
| QQSSATKDVHKGESG | 391 | P55197 | |
| SFKESNEKDTETHAQ | 466 | Q96JN2 | |
| SEDEKHVNSISGTKQ | 2586 | P25054 | |
| SVSKEDTDHEEKASN | 116 | O75475 | |
| HQEEGKEQLSETEGS | 666 | Q13107 | |
| EKEASHSESNVDADS | 491 | Q70EL2 | |
| LSTQHEESADEQKGS | 201 | Q9Y5A6 | |
| AEVESSKNASEDNHS | 131 | Q8NEF9 | |
| DSTKDSSQHTKSSGE | 821 | O95757 | |
| KEQKHSDSGTSEASL | 1256 | Q7Z4S6 | |
| ENQDKEKDSNSSSGS | 41 | Q8TCT6 | |
| SKEESHEQSAEQGKS | 76 | Q14515 | |
| HEQSAEQGKSSSQEL | 81 | Q14515 | |
| QANEEDSSSSLVKDH | 141 | Q7Z699 | |
| KEEHEQNDSISGKTG | 291 | Q92576 | |
| HTASENEEFNKGEST | 866 | Q9GZR1 | |
| TLTDTEHENKSDSEN | 156 | Q9P273 | |
| ETEKHGQADSEDNLS | 876 | Q2NKQ1 | |
| HSNEETNKDFRKDAG | 216 | Q9BQI6 | |
| GHSKETCDNESNKAQ | 356 | P0CG32 | |
| EEEHEEKNSGNSESS | 51 | Q8N3Z6 | |
| NSKTHEGLTEENFKE | 731 | Q9UL62 | |
| SNVHELDTSSEKDKE | 61 | P0C1S8 | |
| ETAKKNHEISNDAGE | 1211 | Q9C0G0 | |
| QKQHKEESHSDGTST | 371 | Q9Y2W2 | |
| LSNDESEAAGLKKSH | 996 | Q9NYI0 | |
| QSEHKTSDADIKSSE | 631 | Q96RL1 | |
| SESKTKSHDDGNIDL | 136 | P18583 | |
| DDSDDESQSSHTGKK | 456 | O94874 | |
| TNEQESTLGQKHTED | 191 | Q96FV9 | |
| DQQSDHSGEKTSKCE | 556 | Q2VY69 | |
| KHNEASTTEVENKNG | 381 | Q7Z570 | |
| EEGSAHQDTAEKNAS | 171 | Q9ULW0 | |
| SNKRGVDTEDAHKSN | 261 | Q9ULJ8 |